Key facts
- This page summarizes Thierry Bernard's Form 4 filing for T2 Biosystems, Inc. (TTOO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Oct 2023, 17:00.
Thierry Bernard - 15 Sep 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)
- Reporting relationship
- Director
- Issuer ticker
- TTOO
- Reported as of
- 15 Sep 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Oct 2023, 17:00:11 UTC
- Prior SEC filing
- 16 Aug 2023
- Next SEC filing
- 05 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Sprague, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thierry Bernard filed Form 4 for T2 Biosystems, Inc. (TTOO) on 11 Oct 2023.
Change
- Previous filing in this sequence was filed on 16 Aug 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TTOO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,300
- Change %
- +46%
- Price
- Shares after
- 7,322
- Date
- 15 Sep 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TTOO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,300
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 15 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,300
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
On October 11, 2022, the reporting person was granted 2,300 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.